Debiopharm – Talk Bio

Actionable Insights Powered by AI

ITM Secures Exclusive Global License for Debiopharm’s CA IX-Targeted Theranostic Pair

ITM, Debiopharm, CA IX, Theranostic Pair, Radiopharmaceutical, Solid Tumors, Cancer Treatment